Category Archives: Medical Affairs

Leveraging Medical Analytics for Better Outcomes

The healthcare industry is witnessing a transformative shift fueled by advanced medical analytics. Imagine unlocking insights that redefine strategies, optimize product launches, and ultimately enhance patient outcomes and care models. It’s not just a vision—it’s a reality for forward-thinking Medical

Elevating Standards: Industry Benchmarks on Building Medical Excellence Groups

In today’s rapidly evolving healthcare landscape, Medical Excellence (Med X) groups play a pivotal role in driving transformation within Medical Affairs. These groups are instrumental in both tactical and strategic phases of evolution. During their inception, Med X teams focus

How Elite Medical Affairs Teams Help Drive a Successful Pharma Product Launch

A highly regulated marketplace, coupled with intensifying competition, have pushed the Medical Affairs function into a significant launch role that extends from the pre-launch phases to well beyond market entry. Best-in-class Medical Affairs groups can become a kind of conduit

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Apple’s announcement for AC Wellness follows on the heels of

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Author:

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. For decades, disease awareness campaigns were a part of the playbook for educating physicians and patients about new

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It

Pharma Executive Talks Timing, Targeting and Trouble for Disease State Awareness Campaigns

In the pharmaceutical sector, disease state awareness campaigns are one of the few ways to reach patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch. While

Creating and Maintaining a Strategic KOL Management and Engagement System

Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small

Role of Medical Affairs Increasing in Oncology Launch

The Medical Affairs function plays a vital role in a host of oncology activities, including identification and engagement of Key Thought Leaders to guidance of commercial strategies and launch resources management. It is becoming increasingly apparent that a successful launch

SPECIAL: 2014-2015 Medical Affairs Consortium Survey Has Launched

Author:

As the healthcare landscape changes, the Medical Affairs function has begun to play increasingly important roles in clinical development, market education, and regulatory compliance. Now, more than ever, leaders can learn valuable lessons from their peers on how they overcome

Best Practices Kicks off 2014-2015 Medical Affairs Consortium

Author:

Medical Affairs functions have a significant influence on a healthcare company’s overall success. As the pharmaceutical, biotech, medical device, and health care technology markets become increasingly competitive and complex, it is crucial for leaders to understand how to best operate

SPECIAL: Highlights from Medical Affairs Consortium 3rd Roundtable

Author:

The Medical Affairs function is constantly changing & leaders are being presented with various obstacles and hurdles they must overcome. One of the key areas that leaders have been struggling with recently is effective thought leader management. In order to

Medical Affairs Consortium: Winning Strategies for Successful Thought Leader Management

Author:

In today’s extremely competitive and demanding healthcare landscape, pharmaceutical, biotech, and medical device organizations heavily rely on thought leaders to influence the important decisions relevant to their products. Likewise, the Medical Affairs function plays a critical role in meeting current